Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 309

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

Open access
Mudd, Philip A., Minervina, Anastasia A., Pogorelyy, Mikhail V., Turner, Jackson S., Kim, Wooseob, Kalaidina, Elizaveta, Petersen, Jan, Schmitz, Aaron J., Lei, Tingting, Haile, Alem, Kirk, Allison M., Mettelman, Robert C., Crawford, Jeremy Chase, Nguyen, Thi H.O., Rowntree, Louise C., Rosati, Elisa, Richards, Katherine A., Sant, Andrea J., Klebert, Michael K., Suessen, Teresa, Middleton, William D., Estepp, Jeremie H., Schultz-Cherry, Stacey, McGargill, Maureen A., Gaur, Aditya, Hoffman, James, Mori, Motomi, Tang, Li, Tuomanen, Elaine, Webby, Richard, Hayden, Randall T., Hakim, Hana, Hijano, Diego R., Allison, Kim J., Allen, E. Kaitlynn, Bajracharya, Resha, Awad, Walid, Van de Velde, Lee-Ann, Clark, Brandi L., Wilson, Taylor L., Souquette, Aisha, Castellaw, Ashley, Dallas, Ronald H., Gowen, Ashleigh, Fabrizio, Thomas P., Lin, Chun-Yang, Brice, David C., Cherry, Sean, Roubidoux, Ericka Kirkpatrick, Cortez, Valerie, Freiden, Pamela, Wohlgemuth, Nicholas, Whitt, Kendall, Wolf, Joshua, Teefey, Sharlene A., O’Halloran, Jane A., Presti, Rachel M., Kedzierska, Katherine, Rossjohn, Jamie, Thomas, Paul G., Ellebedy, Ali H.·2022·Cell

Published version of a preprint

Abstract

SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4+ T cell responses. It is not yet clear whether vaccine-induced follicular helper CD4+ T (TFH) cell responses contribute to this outstanding immunogenicity. Using fine-needle aspiration of draining axillary lymph nodes from individuals who received the BNT162b2 mRNA vaccine, we evaluated the T cell receptor sequences and phenotype of lymph node TFH. Mining of the responding TFH T cell receptor repertoire revealed a strikingly immunodominant HLA-DPB1∗04-restricted response to S167–180 in individuals with this allele, which is among the most common HLA alleles in humans. Paired blood and lymph node specimens show that while circulating S-specific TFH cells peak one week after the second immunization, S-specific TFH persist at nearly constant frequencies for at least six months. Collectively, our results underscore the key role that robust TFH cell responses play in establishing long-term immunity by this efficacious human vaccine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.12.026

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 3

  1. Minervina, 2021, Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination, medRxiv
  2. Sacha, 2010, Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies, Nat. Protoc., 5, 239, 10.1038/nprot.2009.227 · doi:10.1038/nprot.2009.227
  3. Walsh, 2020, Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates, N. Engl. J. Med., 383, 2439, 10.1056/NEJMoa2027906 · doi:10.1056/nejmoa2027906 · Paper page

Cited by

See all 309

Metadata

Authors
Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., Kirk, A. M., Mettelman, R. C., Crawford, J. C., Nguyen, T. H. O., Rowntree, L. C., Rosati, E., Richards, K. A., Sant, A. J., Klebert, M. K., Suessen, T., Middleton, W. D., Estepp, J. H., Schultz-Cherry, S., McGargill, M. A., Gaur, A., Hoffman, J., Mori, M., Tang, L., Tuomanen, E., Webby, R., Hayden, R. T., Hakim, H., Hijano, D. R., Allison, K. J., Allen, E. K., Bajracharya, R., Awad, W., Van de Velde, L.-A., Clark, B. L., Wilson, T. L., Souquette, A., Castellaw, A., Dallas, R. H., Gowen, A., Fabrizio, T. P., Lin, C.-Y., Brice, D. C., Cherry, S., Roubidoux, E. K., Cortez, V., Freiden, P., Wohlgemuth, N., Whitt, K., Wolf, J., Teefey, S. A., O’Halloran, J. A., Presti, R. M., Kedzierska, K., Rossjohn, J., Thomas, P. G., & Ellebedy, A. H.
Venue
Cell
Publisher
Elsevier BV
Published
2022-02
Volume
185
Issue
4
Pages
603-613.e15
ISSN
0092-8674 (ISSN-L)
OpenAlex
W4200466458
Cited by
309
References
56
FWCI
17.62
Type
journal article
Language
en
Open access
bronze
Funders
  • National Center for Advancing Translational Sciences
  • American Lebanese Syrian Associated Charities
  • AbbVie
  • Johnson and Johnson
  • Australian Research Council
  • National Health and Medical Research Council (1173871, 1194036)
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (75N93019C00051, 75N93019C00052, U01AI141990, HHSN272201400008C, 75N93021C00016)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. https://app.cochat.ai/papers/10.1016/j.cell.2021.12.026
The paper
Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., Kirk, A. M., Mettelman, R. C., Crawford, J. C., Nguyen, T. H. O., Rowntree, L. C., Rosati, E., Richards, K. A., Sant, A. J., Klebert, M. K., . . . Ellebedy, A. H. (2022). SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell. https://doi.org/10.1016/j.cell.2021.12.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.